Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1986-10-24
1988-10-11
Schain, Howard E.
Drug, bio-affecting and body treating compositions
Lymphokine
435 68, 435258, 435947, A61K 39018, C12N 110, C12Q 118
Patent
active
047770368
ABSTRACT:
In a process for the culture of Babesia canis, erythrocytes infected by the Babesia canis parasite are incubated in a culture medium suitable for the survival of the erythrocytes and for breeding of the parasites, in the presence of a homologous serum, in the substantially static state, in a normal atmosphere, first of all at a high temperature of 34.degree. to 38.degree. C., then a low temperature, more especially between 0.degree. and 10.degree. C., this cycle being able to be reproduced. The supernatant product is collected which is centrifugated and filtered. A vaccine is prepared against pyroplasmosis in dogs from this floating medium.
REFERENCES:
patent: 3511908 (1970-05-01), Brock et al.
patent: 3849551 (1974-11-01), D'Antonio
patent: 3911097 (1975-10-01), Hanson
patent: 4307191 (1981-12-01), Ristic et al.
patent: 4457915 (1984-07-01), Goodger et al.
patent: 4590072 (1986-05-01), Buening et al.
patent: 4596707 (1986-06-01), Ristic et al.
patent: 4661348 (1987-04-01), Wright
Science, 193, 673-675, (1976), Trager et al.
Am. Jour. Trop. Med. Hyg., 27(5), 1061-1064, (1978), Erp et al.
Mahoney, Exp. Parasitol., 20, 232-241, (1967).
Rhone Merieux
Schain Howard E.
LandOfFree
Process for the culture of Babesia canis, application to the pre does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for the culture of Babesia canis, application to the pre, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for the culture of Babesia canis, application to the pre will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1957454